Inovio Pharmaceuticals
INO
#9373
Rank
โ‚ฌ65.24 M
Marketcap
1,81ย โ‚ฌ
Share price
-0.53%
Change (1 day)
-78.02%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2024 (TTM): โ‚ฌ0.18 Million

According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.19 Million. In 2023 the company made a revenue of โ‚ฌ0.75 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ9.56 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.18 M-75.17%
2023 โ‚ฌ0.75 M-92.13%
2022 โ‚ฌ9.56 M510.49%
2021 โ‚ฌ1.56 M-73.99%
2020 โ‚ฌ6.02 M64.15%
2019 โ‚ฌ3.67 M-86.22%
2018 โ‚ฌ26.64 M-24.28%
2017 โ‚ฌ35.18 M4.65%
2016 โ‚ฌ33.62 M-9.38%
2015 โ‚ฌ37.1 M331.58%
2014 โ‚ฌ8.59 M-11.83%
2013 โ‚ฌ9.75 M213.2%
2012 โ‚ฌ3.11 M-58.72%
2011 โ‚ฌ7.54 M63.27%
2010 โ‚ฌ4.61 M-27.43%
2009 โ‚ฌ6.36 M324.25%
2008 โ‚ฌ1.5 M-54.43%
2007 โ‚ฌ3.29 M25.27%
2006 โ‚ฌ2.62 M-43.05%
2005 โ‚ฌ4.61 M436.43%
2004 โ‚ฌ0.86 M1245.12%
2003 โ‚ฌ0.06 M-64.72%
2002 โ‚ฌ0.18 M
2000 โ‚ฌ5.9 M-32.44%
1999 โ‚ฌ8.74 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ58.40 B 29,551,108.62%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ85.21 B 43,112,188.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.45 M 1,645.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ48.52 B 24,550,936.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ61.38 B 31,056,912.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ39.11 B 19,788,559.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ27.49 B 13,911,498.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.61 M 210.62%๐Ÿ‡บ๐Ÿ‡ธ USA